Loading…
CIK 0001587114 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("ecor1-capital-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | SPONDS ADR | $5.4M | 0.3% | 27,404,070 SH | |
| AKERO THERAPEUTICS INC | COM | $17.8M | 1.1% | 440,000 SH | |
| ALIGOS THERAPEUTICS INC | COM NEW | $731K | 0.0% | 88,569 SH | |
| ANAPTYSBIO INC | COM | $146.5M | 8.7% | 7,880,094 SH | |
| APELLIS PHARMACEUTICALS INC | COM | $260.2M | 15.4% | 11,895,808 SH | |
| ATARA BIOTHERAPEUTICS INC | COM NEW | $3.4M | 0.2% | 573,183 SH | |
| AVIDITY BIOSCIENCES INC | COM | $16.5M | 1.0% | 557,576 SH | |
| BEAM THERAPEUTICS INC | COM | $10.3M | 0.6% | 526,685 SH | |
| BICYCLE THERAPEUTICS PLC | SPONSORED ADS | $7.7M | 0.5% | 910,000 SH | |
| CRINETICS PHARMACEUTICALS IN | COM | $143.8M | 8.5% | 4,288,120 SH | |
| CRISPR THERAPEUTICS AG | NAMEN AKT | $47.3M | 2.8% | 1,389,276 SH | |
| DAY ONE BIOPHARMACEUTICALS I | COM | $6.8M | 0.4% | 862,068 SH | |
| ETON PHARMACEUTICALS INC | COM | $25.8M | 1.5% | 1,989,788 SH | |
| GALAPAGOS NV | SPON ADR | $3.9M | 0.2% | 155,006 SH | |
| GINKGO BIOWORKS HOLDINGS INC | CL A NEW | $8.3M | 0.5% | 1,462,328 SH | |
| IMMUNOME INC | COM | $27.5M | 1.6% | 4,079,415 SH | |
| JANUX THERAPEUTICS INC | COM | $39.7M | 2.4% | 1,469,818 SH | |
| JAZZ PHARMACEUTICALS PLC | SHS USD | $211.9M | 12.6% | 1,706,469 SH | |
| KALARIS THERAPEUTICS INC | COM | $1.6M | 0.1% | 201,718 SH | |
| KEROS THERAPEUTICS INC | COM | $1.9M | 0.1% | 187,500 SH | |
| KURA ONCOLOGY INC | COM | $17.4M | 1.0% | 2,640,298 SH | |
| MADRIGAL PHARMACEUTICALS INC | COM | $24.8M | 1.5% | 75,000 SH | |
| MBX BIOSCIENCES INC | COM | $9.3M | 0.6% | 1,259,273 SH | |
| METSERA INC | COM | $1.4M | 0.1% | 50,000 SH | |
| NEUROGENE INC | COM | $14.9M | 0.9% | 1,271,342 SH | |
| NUVATION BIO INC | *W EXP 02/10/202 | $1.7M | 0.1% | 963,333 SH | |
| ORIC PHARMACEUTICALS INC | COM | $19.1M | 1.1% | 3,418,068 SH | |
| PRIME MEDICINE INC | COM | $1.4M | 0.1% | 700,000 SH | |
| PROTHENA CORP PLC | SHS | $143.4M | 8.5% | 11,584,280 SH | |
| RELAY THERAPEUTICS INC | COM | $1.7M | 0.1% | 641,426 SH | |
| REPLIMUNE GROUP INC | COM | $8.3M | 0.5% | 850,341 SH | |
| SAREPTA THERAPEUTICS INC | COM | $82.5M | 4.9% | 1,292,386 SH | |
| SOLID BIOSCIENCES INC | COM NEW | $2.8M | 0.2% | 744,450 SH | |
| SURROZEN INC | *W EXP 08/01/203 | $777K | 0.0% | 66,665 SH | |
| TANGO THERAPEUTICS INC | COM | $14.6M | 0.9% | 10,630,736 SH | |
| TECTONIC THERAPEUTIC INC | COM | $16.6M | 1.0% | 935,121 SH | |
| TSCAN THERAPEUTICS INC | COM | $915K | 0.1% | 662,833 SH | |
| UNIQURE NV | SHS | $43.7M | 2.6% | 4,123,971 SH | |
| UPSTREAM BIO INC | COM | $367K | 0.0% | 60,000 SH | |
| VERVE THERAPEUTICS INC | COM | $5.7M | 0.3% | 1,250,000 SH | |
| VOYAGER THERAPEUTICS INC | COM | $13.2M | 0.8% | 3,917,546 SH | |
| WHITEHAWK THERAPEUTICS INC | COM | $3.7M | 0.2% | 2,082,000 SH | |
| XENCOR INC | COM | $65.4M | 3.9% | 6,144,767 SH | |
| ZYMEWORKS INC | COM | $205.6M | 12.2% | 17,259,548 SH |
| 13F-HR |
| 0000935836-26-000415 |
| $2.06B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000935836-25-000506 | $1.69B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000935836-26-000270 | $2.36B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000935836-25-000338 | $1.69B | View |